Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

Clinical trial NCT07671534 · RECRUITING

Trial details

NCT number: NCT07671534
Sponsor: Sarcoma Oncology Research Center, LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.